I could not find anything about class actions suits against it but here
In October 2002, the Food and Drug Administration (FDA) approved
buprenorphine monotherapy product, Subutex®, and a
buprenorphine/naloxone combination product, Suboxone®, for use in opioid addiction treatment. The combination product is designed to decrease the potential for abuse by injection.